Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum NervGen Pharma Corp V.NGEN

Alternate Symbol(s):  NGENF

Healthcare
NervGen Pharma Corp. is a clinical-stage biotech company. The Company is engaged in discovery, development and commercialization of pharmaceutical products for the treatment of nervous system damage due to injury or disease. The Company is advancing its lead compound, NVG-291, for the treatment of spinal cord injury (SCI), Alzheimer’s disease (AD) and multiple sclerosis (MS). Its NVG-291 is a... see more

Bullboard (TSXV:NGEN)

View:
1 2 3 4 5 6 Next
Post by whytestockson Aug 06, 2024 2:47pm

NervGen Pharma to Present at the Canaccord Genuity 44th Annu

News; $NGENF NervGen Pharma to Present at the Canaccord Genuity 44th Annual Growth ConferenceVancouver, British Columbia--(Newsfile Corp. - August 6, 2024) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB ...more  
198
Comment by Nosleepon Jul 11, 2024 8:34pm

RE:RE:Stock options

who cares, you either own it and win with them, or lose with them. Stock is do or die, under .50 cents if drug shows no results, so the options are worthless anyways at that point. If the drug works ...more  
331
Discussion
Comment by wallpaper2on Jul 10, 2024 10:03am

RE:Stock options

VERY TACKY !! Gutless move by weak gutless Board. 
122
Discussion
Post by greenlandon Jun 26, 2024 8:53pm

2nd Annual Spinal Cord Injury Investor Symposium ("2nd SCIIS

NervGen Pharma to Present at the 2nd Annual Spinal Cord Injury Investor Symposium   V.NGEN | 6 days ago Vancouver, British Columbia--(Newsfile ...more  
269
Post by deepoil0808on Jun 07, 2024 4:05pm

Stock options

The issuance of stock options does not inspire confidence as these options were given away at cost, with no premium in them. I would have issued stock options (sat triple the amount or 3 million ...more  
316
Discussion
Post by deepoil0808on Jun 05, 2024 7:35pm

Safest strategy is to WAIT for results first...then decide.

This stock is a BINARY stock, meaning will be very volatile when results are released. Best strategy is to wait for trial results before buying.  If trials fail, then stock will plunge and it ...more  
324
Post by deepoil0808on May 16, 2024 12:46pm

Sure reads like a very disappointing press release

I think I am reading the tea leaves correctly and that the results will be inconclusive. We learned more on the delay in enrollment.   They are having difficulty finding a homogenous group ...more  
282
Post by deepoil0808on May 15, 2024 11:32pm

CEO.CA post on a director

A poster brought up issues that one director is having in Court. If true, this type of alledged conduct is very concerning, especially when person is sitting as director of NGEN.  Does not ...more  
255
Post by deepoil0808on May 15, 2024 6:28pm

2 issues of concern???? PP + delays in patients

I read the press releases of the corporation and there are 2 possible  concerns: (a)   Timing of PP -  the corporation said that they needed $$$ so they did PP. But did they ...more  
190
Post by ENEMENEMYNEMOon Apr 25, 2024 8:53pm

PR Firm

This reeks of desperation. Makes zero sense. If results are positive then it will sell itself. Maybe they are gearing up for a stock offering!
128
Post by deepoil0808on Apr 25, 2024 8:38pm

Sedar filings HINT at inconclusive evidence (more testing)?

I conducted a review of the insider buying from February 15th 2024 to date.   The date of February 15th is when there were leaks of one patient doing well, followed up later with free ...more  
321
1 2 3 4 5 6 Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities